Study identifier:D133FR00195
ClinicalTrials.gov identifier:NCT05918042
EudraCT identifier:N/A
CTIS identifier:N/A
Multicentre, non-interventional, observational, prospective study to evaluate 1-st line treatment approaches in HRD+ ovarian cancer patients in Russian Federation
ovarian cancer
N/A
No
-
Female
400
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|